-
1201
A Smart Nanomedicine Unleashes a Dual Assault of Glucose Starvation and Cuproptosis to Supercharge αPD‐L1 Therapy
Published 2025-01-01“…Among all, emerging strategies targeting cancer metabolism have shown great potency in treating cancers with immunotherapy. Here, alteration in glucose and copper metabolisms is found to synergistically regulate PD‐L1 expression in lung cancer cells. …”
Get full text
Article -
1202
Identification of Hepatocellular Carcinoma Subtypes Based on Global Gene Expression Profiling to Predict the Prognosis and Potential Therapeutic Drugs
Published 2025-01-01“…TIDE was employed to predict the patient response to immunotherapy. Finally, drug sensitivity was analyzed using the oncoPredict algorithm. …”
Get full text
Article -
1203
Translating Unconventional T Cells and Their Roles in Leukemia Antitumor Immunity
Published 2021-01-01“…Recently, cell-mediated immune response in malignant neoplasms has become the focus in immunotherapy against cancer. However, in leukemia, most studies on the cytotoxic potential of T cells have concentrated only on T cells that recognize peptide antigens (Ag) presented by polymorphic molecules of the major histocompatibility complex (MHC). …”
Get full text
Article -
1204
Single-cell sequencing uncovers the mechanistic role of DAPK1 in glioma and its diagnostic and prognostic implications
Published 2025-01-01“…An in-depth examination of DAPK1’s specific mechanisms in glioblastoma could elucidate its role in immunotherapy response. Targeting the DAPK1 gene may offer therapeutic benefits for glioma patients.…”
Get full text
Article -
1205
High-dose ascorbic acid synergizes with anti-PD1 therapy in non-small cell lung cancer in vitro and in vivo models
Published 2025-01-01“…This study aimed to elucidate the effects of high-dose AA on anti-PD1 immunotherapy in NSCLC.MethodsThe combined effects of high-dose AA and anti-PD1 were investigated using a coculture model of H460 cells and CD8+ T cells and an LLC1 lung cancer syngeneic mouse model. …”
Get full text
Article -
1206
Reliability of mpMRI in diagnosing cancer prostate following intravesical BCG for bladder cancer
Published 2024-11-01“…Abstract Background Detecting carcinoma prostate (CaP) after intravesical Bacillus Calmette Guerin (BCG) immunotherapy for non‐muscle invasive bladder cancer (NMIBC) poses diagnostic challenges. …”
Get full text
Article -
1207
SILAC-based quantification reveals modulation of the immunopeptidome in BRAF and MEK inhibitor sensitive and resistant melanoma cells
Published 2025-01-01“…This finally led to the discovery of new potential targets for cancer immunotherapy.…”
Get full text
Article -
1208
Neo-BCV: A Novel Bacterial Liquid Complex Vaccine for Enhancing Dendritic Cell-Mediated Immune Responses Against Lung Cancer
Published 2025-01-01“…Background: In the past decade, immunotherapy has become a major choice for the treatment of lung cancer, yet its therapeutic efficacy is still relatively limited due to the various immune escape mechanisms of tumors. …”
Get full text
Article -
1209
Redox-dependent purine degradation triggers postnatal loss of cardiac regeneration potential
Published 2025-02-01Get full text
Article -
1210
Single-cell RNA-seq analysis reveals microenvironmental infiltration of myeloid cells and pancreatic prognostic markers in PDAC
Published 2025-01-01“…Further, patients with high-risk scores had a lower likelihood of benefiting from immunotherapy. Conclusion Using bulk RNA-seq and single-cell RNA-seq, we analyzed myeloid heterogeneity at the single-cell level, and we developed an 8-gene model that predicts survival outcomes and immunotherapy response in PADC.…”
Get full text
Article -
1211
RETRACTED ARTICLE: Construction and validation of a machine learning-based immune-related prognostic model for glioma
Published 2024-10-01“…These findings provide new perspectives for glioma prognosis assessment and immunotherapy.…”
Get full text
Article -
1212
Development of a prognostic model based on four genes related to exhausted CD8+ T cell in triple-negative breast cancer patients: a comprehensive analysis integrating scRNA-seq and...
Published 2025-02-01“…Although improving TEX and enhancing effector function are promising strategies for strengthening immunotherapy, their role in the pathogenesis of TNBC remains unclear. …”
Get full text
Article -
1213
Identification of a novel immunogenic cell death-related classifier to predict prognosis and optimize precision treatment in hepatocellular carcinoma
Published 2025-01-01“…In contrast, low ICD score corresponded to abundant immune cell infiltration, high sensitivity to immunotherapy and a positive prognosis, indicating an “immune-hot” phenotype. …”
Get full text
Article -
1214
Successful Neoadjuvant Therapy with Pembrolizumab Monotherapy for Advanced Ascending Colon Cancer
Published 2023-07-01“…However, the role of immunotherapy in the neoadjuvant setting remains uncertain. …”
Get full text
Article -
1215
T-Cell Traffic Jam in Hodgkin's Lymphoma: Pathogenetic and Therapeutic Implications
Published 2011-01-01“…We will finally overview some of the strategies of cellular immunotherapy applied in patients with HL.…”
Get full text
Article -
1216
Clinical Diagnosis of an Autoimmune Encephalitis Presented as a Manic Episode with Psychotic Symptoms: A Case Report
Published 2022-01-01“…We report one case that highlights the variability of clinical manifestations, which in the absence of antibodies was treated with immunotherapy with good response. Conclusion. In places where there is no antibody measurement, or when its measurement is negative, the clinical suspicion supported by CSF studies, magnetic resonance imaging, and electroencephalographic recording, should guide us to start immunotherapeutic treatment early. …”
Get full text
Article -
1217
Immunotherapeutic Strategies for Alzheimer's Disease Treatment
Published 2009-01-01“…Active and/or passive immunization against the amyloid-β peptide has been proposed as a method for preventing and/or treating AD. Immunotherapy represents fascinating ways to test the amyloid hypothesis and offers genuine opportunities for AD treatment, but requires careful antigen and antibody selection to maximize efficacy and minimize adverse events.…”
Get full text
Article -
1218
Interactions between the tumor microbiota and breast cancer
Published 2025-01-01“…Gut microbes and their metabolites influence the development of breast cancer by regulating the tumor immune response, estrogen metabolism, chemotherapy, and immunotherapy effects. It was previously thought that there were no microorganisms in breast tissue, but it is now thought that there are microorganisms in breast cancer that can affect the outcome of the disease. …”
Get full text
Article -
1219
Editorial: Community series in BCR signaling and B cell activation, volume 2
Published 2025-01-01Get full text
Article -
1220
Intestinal Immune Imbalance is an Alarm in the Development of IBD
Published 2023-01-01“…These events indicate that intestinal immune imbalance is an alarm for IBD development, further opening new possibilities for the unprecedented development of immunotherapy for IBD.…”
Get full text
Article